CMV423
id:
cmv423-192-15926212
title:
CMV423
text:
CMV423 (2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide) is an experimental antiviral drug that has been studied for the treatment of cytomegalovirus (CMV) infection and human herpesvirus 6 (HHV-6) infection. The drug was investigated by Sanofi-Aventis, but its development was discontinued by 2018 before entering clinical trials.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/CMV423
date created:
date modified:
2023-04-06T03:17:09Z
main entity:
{"identifier":"Q15410869","url":"https://www.wikidata.org/entity/Q15410869"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/f2/CMV423.svg","width":375,"height":480}
fields total:
13
integrity:
15